# Pharmacokinetics and Excretion of Albendazole and Its Metabolites in Saliva

> **NCT05453045** · NA · UNKNOWN · sponsor: **Universidad Nacional de Salta** · enrollment: 12 (estimated)

## Conditions studied

- Pharmacological Action

## Interventions

- **DRUG:** Albendazole

## Key facts

- **NCT ID:** NCT05453045
- **Lead sponsor:** Universidad Nacional de Salta
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-18
- **Primary completion:** 2022-08-30
- **Final completion:** 2022-12-16
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2022-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05453045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05453045, "Pharmacokinetics and Excretion of Albendazole and Its Metabolites in Saliva". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT05453045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*